Paramount Skydance Corporation Class B Common Stock PSKY
Communication Services · Entertainment · Synthos Deep Dive · 2026-07-03
The Overview
Paramount Skydance owns CBS, Paramount Pictures, Paramount+, Pluto TV, Nickelodeon, MTV, Comedy Central and BET. It makes money three ways: ads, subscriptions/affiliate fees from cable and streaming, and movies. The old cable-TV business is shrinking as people cut the cord; streaming is growing but only recently started making money. David Ellison's Skydance took control in 2024, and the company is now trying to buy Warner Bros. Discovery — a giant deal funded mostly with borrowed money.
Is the stock cheap or expensive? On paper it looks cheap (you pay less than 1× its yearly sales), but it carries a lot of debt and doesn't reliably make a profit under standard accounting. So "cheap" here means "risky and complicated," not "bargain."
Our verdict is Watch — interesting, but too many moving parts to buy today. Wall Street agrees: the average analyst rates it a Sell, and their price target is right where the stock already trades.
Here's what our three scores mean in everyday terms:
- Downside Risk 8/10 (high). Lots of debt, a jumpy stock (it has fallen ~90% from its old peak), and a huge merger that could go well or badly.
- Growth Quality 3/10 (weak). Sales are barely growing and the core TV business is in slow decline; the bright spot is cost-cutting and streaming, not real growth.
- Exponential Potential 3/10 (low). This is not a fast-growing tech story. The only way it "jumps" is if the Warner deal works — that's a gamble on a merger, not organic momentum.
The one big worry: the Warner Bros. Discovery acquisition. It could transform the company — or bury it in debt if the economics or approvals go the wrong way.
Putting a number on it: our fair-value estimate is $10 against a current price of $10.88 — a premium price for a business we still like.
Our summary metrics
High leverage (net debt/adj-EBITDA ~3× pre-WBD), beta 1.44, −90% max drawdown, GAAP losses, and a transformational $59B merger overhang.
~2% forward revenue CAGR, secular linear-TV decline, thin/negative GAAP margins; only cost-out and DTC mix are improving.
Not an exponential — it is a levered turnaround/merger-arb; the only "acceleration" is the WBD deal, which is an event, not organic growth.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, We don’t publish a reverse-DCF cross-check for pre-profit companies — negative or missing earnings break that math — so take this number on our modeling alone.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Not an exponential — it is a levered turnaround/merger-arb; the only "acceleration" is the WBD deal, which is an event, not organic growth.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $10 (high $10 / low $10; 0 Strong-Buy · 8 Buy · 10 Hold · 11 Sell → "Sell") — context, not our anchor |
| Valuation | Negative GAAP P/E · ~16× FY26E · ~13× FY27E · ~8× FY30E adj. EPS · EV/S 0.9× · EV/EBITDA negative (impairment-distorted) |
| Technicals | Downtrend — $10.39, −47% off 52-wk high, below the 200-DMA, RSI 48, −20% 12-mo (SPY +21%) |
| Conviction | None — 0 expert voices, 0 traceable claims in the Synthos KB |
| Position sizing | Not a core holding; special-situation/speculative sizing only, 0–1% if at all |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for PSKY — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $10.88, 15% above the 50-day average ($9), 2% below the 200-day average ($11) — a mixed trend. 45% below the 52-week high of $20, 39% above the 52-week low of $8.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $10.88 is currently inside the band (band $8–$11).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 73.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently above its signal line by 0.11, positive momentum.
Relative performance vs S&P 500 & its sector (XLC (sector)), set to 100 a year ago
Solid = PSKY · dashed = S&P 500 · dotted = XLC (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Paramount Skydance Corporation (NASDAQ: PSKY) is a global media and entertainment company, formed when David Ellison's Skydance merged with the former Paramount Global (itself the old ViacomCBS). Ellison is CEO. The business runs in three pillars:
- TV Media — the CBS Television Network and stations, plus cable brands (Nickelodeon, MTV, Comedy Central, BET, CBS Sports, Showtime/Paramount Network) and international channels (Network 10, Channel 5, Telefe). This is the cash-cow-in-decline: profitable but shrinking with cord-cutting.
- Direct-to-Consumer (DTC) — Paramount+, Pluto TV (free ad-supported), and BET+. The growth engine; only recently EBITDA-positive.
- Filmed Entertainment (Studios) — Paramount Pictures and related labels; hit-driven, lumpy.
Fiscal year ends December 31. HQ New York; ~18,600 employees; beta 1.44; controlled historically via National Amusements, now under Skydance/Ellison control.
Revenue mix (from filings):
- By product (FY2024, the last clean segmentation on file): Affiliate & subscription $13.15B (45%) · Advertising $10.30B (35%) · Licensing & other $4.95B (17%) · Theatrical $0.81B (3%). The subscription/affiliate line is now the largest — the streaming pivot is visibly reshaping the mix (Affiliate & subscription was $8.4B in 2021).
- By geography (FY2024): United States $23.7B (81%) · Non-US $5.5B (19%). Heavily US-centric — a domestic-advertising and domestic-cord-cutting exposure.
2. The expert thesis (traceable)
There is no expert coverage of PSKY in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0. No podcast/investor-panel voice in our tracked universe has made a traceable, dated claim on this name.
That means this note carries no conviction-track signal — the verdict is entirely fundamentals- and quant-driven, built from the FMP financials, analyst estimates, the technical block, and management's own SEC-filed guidance. We will not manufacture conviction we do not have. If and when a tracked expert makes a dated claim on PSKY, this section — and the conviction rating — will be updated with a real claim_id.
For the record, the sell-side (a different, lower-weighted signal than our KB experts) is net-negative: 0 Strong-Buy, 8 Buy, 10 Hold, 11 Sell → consensus "Sell," with a price target of exactly $10 (= the current price). The Street sees no upside from here on a standalone basis.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 8 · High | Total debt $14.8B / net debt $11.5B vs guided adj-EBITDA ~$3.8B → ~3× leverage before the WBD deal adds ~$59B of financing. Beta 1.44, −89.6% max drawdown, GAAP net losses, and a merger overhang. |
| Growth Quality | 3 · Weak | Forward revenue CAGR ~2% (FY25 $29.2B → FY30E $32.2B); secular linear-TV decline; TTM EBIT margin −17% (impairment-distorted); the only genuine improvements are cost-out and DTC mix. |
| Exponential Potential | 3 · Low | Not an exponential. ~2% organic growth with no acceleration. The one non-linear event is the WBD acquisition — an M&A bet, not compounding. A microcap could still re-rate hard on deleveraging, hence not a 1. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities. Because the whole story pivots on a binary merger, treat the range as unusually wide and event-driven.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | WBD deal closes on favorable terms; cost-out + DTC profit accelerate; adj. EPS reaches ~$1.10–1.15 (FY28E) and the market pays ~13–14× for a deleveraging, scaled streamer. | ~$15 (+44%) |
| Base (our anchor) | Standalone execution roughly hits estimates — FY27E adj. EPS ~$0.82; a low-growth, still-levered media name earns a modest ~12–13×. Deal risk offsets deal upside. | ~$10 (~flat) |
| Bear | Deal falls through or closes on punishing terms; ad/linear declines steepen; leverage forces dilution or distressed refinancing; adj. EPS ~$0.50 at a ~9× trough multiple. | ~$5 (−52%) |
Synthos fair value = the base case, ~$10 (roughly flat), with the full $5–$15 span as the honest range. This deliberately matches the Street's $10 — not because we're anchoring to it, but because our independent standalone math lands in the same place: a low-growth, high-leverage media asset is worth roughly what it trades for, and the merger genuinely cuts both ways. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). PSKY is neither — it is a levered turnaround with an M&A wildcard:
- Forward growth: revenue CAGR FY25→FY30E ~2% ($29.2B → $32.2B). This is a no-growth top line.
- Acceleration (2nd derivative): essentially flat-to-slightly-positive on revenue; the improving line is profitability, not sales — adj. EBITDA guided to $3.8B and a $3B+ efficiency program targeted through 2027 (>$2.5B run-rate by end-2026, per management). That is margin recovery, not growth acceleration.
- Room to run: at an $11.3B market cap the stock could re-rate sharply on successful deleveraging or a well-received WBD integration — the "room" exists. But the driver would be a balance-sheet and M&A outcome, not a widening TAM.
- The WBD event: the only non-linear lever. Combining CBS/Paramount+ with HBO Max/Warner is a genuine scale play against Netflix and Disney — but it is financed with ~$59B (a $10B debt facility plus $49B bridge syndicated to 18 banks, per the Q1'26 letter), so the combined entity is a high-leverage, high-integration-risk proposition. Upside is real; so is the wipeout tail.
Exponential Potential: Low (3/10). Own this only as a special situation — a bet on deleveraging and merger execution — never as a growth compounder. It does not belong in a Synthos "next-exponential" sleeve.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $29.21B, flat vs FY24 $29.21B and down from FY23 $29.65B. A stalled top line — the definition of an ex-growth media asset.
- Quarterly trajectory: Q1'25 $7.19B → Q2 $6.85B → Q3 $6.70B → Q4 $8.47B → Q1'26 $7.35B (+2% YoY, per management). Stable-to-soft, seasonal.
- GAAP profitability is negative and volatile: FY25 GAAP EBITDA −$4.93B and net income −$6.19B (EPS −$9.32) — dominated by large goodwill/intangible impairments (goodwill fell from $10.5B to $1.6B over the year). This is a write-down of past M&A, not an operating cash burn. Read GAAP EBITDA here with heavy skepticism — it is impairment-distorted.
- Adjusted / operating reality is better: Q1'26 alone posted operating income $701M and reported EPS +$0.25 (beat the $0.15 estimate); management guides FY26 to $3.8B adjusted EBITDA. The gap between −$4.9B GAAP EBITDA and +$3.8B adjusted EBITDA is almost entirely impairments — investors should track the adjusted figure and cash flow.
- Cash flow: FY25 operating CF $485M, capex −$162M, FCF ~$323M (an anemic ~2.6% FCF yield). Thin but positive — the business is not burning cash operationally.
- Balance sheet: total debt $14.8B, cash $3.27B, net debt $11.5B. Against guided adj-EBITDA of $3.8B that's ~3× leverage — elevated for a no-growth business, and before the WBD financing. Current ratio 1.1×.
6. Valuation — priced in or room?
On trailing GAAP numbers the multiples are meaningless (negative EPS, negative EBITDA from impairments). The honest lenses:
- Sales & cash flow: EV/Sales ~0.9×, P/S 0.38×, P/FCF ~38× (FCF is thin). Cheap on sales, not on cash flow.
- Forward adjusted EPS: on consensus adj. EPS the P/E runs ~16× FY26E ($0.63) → ~13× FY27E ($0.82) → ~8× FY30E ($1.28). Optically inexpensive if the earnings recovery lands — but that's a big "if" for a ~2%-growth, ~3×-levered name.
- Book: P/B 0.59× — trading below stated book value, consistent with the market pricing in further impairment/merger risk.
Street targets (context, not our anchor): consensus, high, and low are all $10 — the Street sees the stock as fairly valued to slightly rich on a standalone basis, with a "Sell" grade tilt. Our base-case FV also lands at ~$10. The upside here is not a re-rating of a cheap earnings stream; it is an event (successful WBD close + deleveraging). Without that, this is a value trap risk, not a value buy.
7. Technicals (from the tech block)
- Trend: down. $10.39 sits below the 200-DMA ($12.73) and roughly at the 50-DMA ($10.42). The 50 well below the 200 is a death-cross posture. MACD −0.13 (mildly negative).
- Location: −47.3% off the 52-week high ($19.73), +18.2% off the 52-week low ($8.79). The stock has round-tripped a large 2025 rally. Max drawdown from peak −89.6% — a reminder of how much value this franchise has destroyed over the cycle.
- Momentum: RSI(14) 47.6 — neutral, neither overbought nor oversold; no technical "buy the dip" signal.
- Relative strength (the tell): PSKY −19.6% 12-mo vs SPY +20.6% and QQQ +30.3% — massive, persistent underperformance of both the market and the Nasdaq. The only bright spot is +12.3% over the last 3 months (vs SPY +13.7%) — roughly in line, not leading.
- Read: technicals do not confirm a bottom. Below the 200-DMA, in a multi-year downtrend, with neutral momentum. There is no technical reason to rush; a decisive reclaim of the 200-DMA (~$12.70) on volume would be the first constructive signal.
8. Moat & competitive position
Paramount's "moat" is a library and brand portfolio — CBS, Paramount Pictures' catalog, Nickelodeon, MTV, BET, Star Trek, and the Taylor Sheridan hit machine (Landman, The Madison, Mayor of Kingstown). CBS remains a genuine broadcast asset (management notes CBS held 13 of the top-20 primetime series). But the moat is eroding structurally: linear TV is in secular decline, and in streaming Paramount+ is a sub-scale #4/#5 against Netflix, Disney+, and Amazon, competing on spend it can less afford. The strategic logic of the WBD acquisition is precisely to buy scale (HBO Max + Warner library) to close that gap — an admission that standalone scale is insufficient.
Peer set (market cap, from file): these are FMP's size-matched comps, not true strategic peers — Frontier Communications $9.6B, Interpublic $8.9B, KT Corp $8.5B, Liberty Live $9.9B, Nexstar $5.5B, New York Times $12.0B, Pearson $10.0B, Sirius XM $10.3B, TIM SA $10.4B. The relevant strategic competitors are Netflix, Disney, Warner Bros. Discovery (the target), Comcast/NBCU, and Amazon/Apple — all far larger or better-capitalized in streaming. On that field PSKY is a challenger, not a leader.
9. Management, capital allocation & guidance
- Leadership: David Ellison (Skydance) is CEO after the 2024 control transaction; Andrew Brandon-Gordon is COO/Chief Strategy Officer. This is a new, founder-driven regime explicitly reshaping the company — high agency, but an unproven public-market track record at this scale.
- Capital allocation: dominated by (a) the $3B+ efficiency program through 2027 and (b) the WBD acquisition financed with ~$59B (a $10B debt facility plus a $49B bridge syndicated to 18 global banks, with a portion of new equity syndicated to strategic investors). A small dividend ($0.20/yr) and minimal buyback ($92M FY25). Capital priority is clearly deleveraging + the merger, not shareholder returns.
- Insider activity: the sampled window (May–Jun 2026) shows routine equity awards, RSU vesting, and tax-withholding ("F-InKind") dispositions — e.g., director Barbara Byrne awards, COO Brandon-Gordon RSU conversions. No open-market discretionary buying or alarming cluster of sales — normal comp mechanics, not a signal either way.
- Management's own guidance (half-weighted — self-interested): The Q1'26 shareholder letter (SEC 8-K / EX-99, filed 2026-05-04) is a genuine earnings release and states management's own forward view: reaffirming full-year 2026 outlook of ~$30B revenue and $3.8B adjusted EBITDA; DTC revenue +11% YoY to $2.4B with Paramount+ +17%; DTC adj. EBITDA of $251M (10% margin) and "accelerating DTC revenue and profit in 2026"; $3B+ in efficiencies through 2027 (>$2.5B run-rate by end-2026); and "significant progress toward closing the WBD acquisition by end of Q3'26." These are management's self-interested words — real, dated, and material, but weighted accordingly. The credible, checkable parts are the DTC growth and cost-out; the deal-close timeline is a target, not a certainty.
10. Catalysts & what to watch
- Next earnings: 2026-07-30 (Q2'26; Street EPS $0.16, revenue ~$6.87B). Watch: DTC subscriber adds and DTC margin, ad trends, and any change to the $30B/$3.8B full-year guide.
- The WBD acquisition (the whole ballgame): regulatory approval, final financing terms, and the combined-entity pro-forma leverage. Targeted close end-Q3'26 — this single event dominates the equity.
- Cost-out delivery: progress toward the $2.5B run-rate efficiencies by end-2026 — the clearest lever management controls.
- DTC profitability inflection: sustained streaming EBITDA growth as churn/price increases play through.
- Balance-sheet: any refinancing, dilution, or asset sales tied to funding the deal.
Thesis tripwires (what would change the call): WBD deal termination or a materially worse-than-expected financing/leverage structure (bearish); a clean close with credible deleveraging plan (bullish); two quarters of DTC margin backsliding; or a guide-down on the $3.8B adj-EBITDA target.
11. Key risks
- Merger risk (structural, dominant): the $59B-financed WBD acquisition is binary — regulatory, financing, and integration risk all at once. A bad outcome could impair the equity badly given existing leverage.
- Leverage: ~3× net-debt/adj-EBITDA before the deal; the combined entity would be materially more levered. Rising-rate or refinancing stress is a real tail.
- Secular linear-TV decline: the profit engine (TV Media affiliate + advertising) is in structural erosion; DTC must scale profitably fast enough to offset it — not yet proven.
- Streaming sub-scale: Paramount+ competes against far larger, better-funded platforms; content spend is a treadmill.
- GAAP volatility / further impairments: FY25 already took multi-billion write-downs; more are possible if segment values keep resetting.
- No expert coverage: we have zero KB conviction to lean on — the entire thesis rests on quant + fundamentals + management's own (discounted) word.
- Governance/control: founder-controlled, new regime; minority holders ride along on Ellison's strategy.
12. Verdict, position sizing & monitoring
Watch. PSKY is a levered media turnaround wrapped around a company-defining merger. The standalone business is roughly fairly valued (our base FV ~$10 ≈ Street $10 ≈ current price), profitability is genuinely recovering on cost-out and DTC mix, and the library/CBS assets have real value. But the combination of ~3× leverage, ~2% revenue growth, GAAP losses, a −90% historical drawdown, a "Sell"-tilted Street, zero expert conviction, and a $59B binary merger means there is no margin of safety and no clear catalyst to underwrite today. This is a situation to study, not size into, until the WBD deal terms and combined-entity balance sheet are visible.
- Sizing: not a core position. If an investor has a specific, researched merger-arb or deleveraging thesis, special-situation sizing only (0–1%). For a general portfolio: pass and watch.
- Monitoring: re-underwrite on the WBD close (terms + pro-forma leverage), the Q2'26 print (2026-07-30), and cost-out delivery. A clean deal close with a credible deleveraging path could move this to a Buy — Tactical; a broken deal or a punishing financing could move it toward Avoid.
- Single biggest risk: the Warner Bros. Discovery acquisition — it is simultaneously the biggest upside lever and the biggest wipeout risk. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $10.39.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of PSKY in the Synthos knowledge base, so no
claim_ids are cited. This note is fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation), and we state plainly when conviction is absent. - Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K/EX-99 dated 2026-05-04. Forward figures are analyst consensus (FMP) or management guidance, each labeled as estimates.
- GAAP caveat: FY25 GAAP EBITDA/net income are distorted by large goodwill/intangible impairments; adjusted EBITDA (~$3.8B guided) and free cash flow are the more representative operating measures.
- Management caveat: the Q1'26 shareholder-letter guidance is management's own, self-interested word — half-weighted by design.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").